Squarepoint’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-28,714
| Closed | -$1.17M | – | 4358 |
|
|
2025
Q4 | $1.17M | Buy |
+28,714
| New | +$1.25M | ﹤0.01% | 2474 |
|
|
2025
Q3 | – | Sell |
-4,383
| Closed | -$228K | – | 4434 |
|
|
2025
Q2 | $228K | Buy |
+4,383
| New | +$241K | ﹤0.01% | 3894 |
|
|
2025
Q1 | – | Sell |
-12,403
| Closed | -$849K | – | 4692 |
|
|
2024
Q4 | $849K | Buy |
+12,403
| New | +$864K | ﹤0.01% | 3218 |
|
|
2024
Q3 | – | Sell |
-122,925
| Closed | -$8.52M | – | 4176 |
|
|
2024
Q2 | $8.52M | Buy |
122,925
+6,557
| +6% | +$478K | 0.01% | 1024 |
|
|
2024
Q1 | $9.32M | Buy |
116,368
+32,793
| +39% | +$2.92M | 0.02% | 1036 |
|
|
2023
Q4 | $9.15M | Sell |
83,575
-12,650
| -13% | -$1.31M | 0.02% | 1000 |
|
|
2023
Q3 | $9.7M | Buy |
96,225
+77,905
| +425% | +$8.95M | 0.02% | 817 |
|
|
2023
Q2 | $2.49M | Buy |
+18,320
| New | +$2.24M | 0.01% | 1521 |
|
|
2022
Q3 | – | Sell |
-7,632
| Closed | -$731K | – | 3044 |
|
|
2022
Q2 | $731K | Buy |
+7,632
| New | +$916K | ﹤0.01% | 1792 |
|
|
2022
Q1 | – | Sell |
-7,442
| Closed | -$1.05M | – | 2914 |
|
|
2021
Q4 | $1.05M | Buy |
+7,442
| New | +$1.05M | ﹤0.01% | 1659 |
|
|
2021
Q1 | – | Sell |
-9,545
| Closed | -$1.07M | – | 3177 |
|
|
2020
Q4 | $1.07M | Buy |
9,545
+5,953
| +166% | +$564K | 0.01% | 1286 |
|
|
2020
Q3 | $283K | Sell |
3,592
-12,007
| -77% | -$979K | ﹤0.01% | 1839 |
|
|
2020
Q2 | $1.12M | Sell |
15,599
-31,410
| -67% | -$2.19M | 0.02% | 873 |
|
|
2020
Q1 | $2.69M | Buy |
47,009
+14,493
| +45% | +$1.34M | 0.07% | 369 |
|
|
2019
Q4 | $3.64M | Buy |
32,516
+29,272
| +902% | +$3.12M | 0.02% | 614 |
|
|
2019
Q3 | $312K | Sell |
3,244
-9,569
| -75% | -$898K | ﹤0.01% | 1875 |
|
|
2019
Q2 | $1.1M | Buy |
+12,813
| New | +$1.05M | 0.01% | 1214 |
|
|
2019
Q1 | – | Sell |
-19,121
| Closed | -$1.23M | – | 2175 |
|
|
2018
Q4 | $1.23M | Buy |
+19,121
| New | +$1.31M | 0.01% | 844 |
|
|
2018
Q3 | – | Sell |
-16,454
| Closed | -$1.2M | – | 2009 |
|
|
2018
Q2 | $1.2M | Buy |
16,454
+4,357
| +36% | +$296K | 0.02% | 823 |
|
|
2018
Q1 | $766K | Buy |
+12,097
| New | +$722K | 0.01% | 911 |
|
|
2017
Q4 | – | Sell |
-5,101
| Closed | -$268K | – | 2113 |
|
|
2017
Q3 | $268K | Buy |
+5,101
| New | +$256K | 0.01% | 1233 |
|
|
2016
Q2 | – | Sell |
-7,775
| Closed | -$326K | – | 1131 |
|
|
2016
Q1 | $326K | Buy |
7,775
+1,575
| +25% | +$61.8K | 0.03% | 796 |
|
|
2015
Q4 | $273K | Buy |
+6,200
| New | +$269K | 0.03% | 841 |
|
Other funds holding CNMD
CB
Squarepoint's CNMD Position: Q1 2026 in Review
Squarepoint sold out of CONMED (CNMD) in Q1 2026, closing a stake of 28,714 shares — an estimated $1.17M sold.
Squarepoint first reported a position in CNMD in Q4 2015 and held it in 23 quarters. The position peaked at $9.7M in Q3 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Squarepoint reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
- Squarepoint sold 28,714 CONMED shares in Q1 2026, an estimated $1.17M.
- Squarepoint first reported a position in CONMED in Q4 2015 and held it in 23 quarters.
- Squarepoint's CONMED position peaked at $9.7M in Q3 2023.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.